Japan Approves the World’s First Treatment Made With Reprogrammed Human Cells
SMRTR summary
Japan became the first country to approve medical treatments made from reprogrammed human stem cells, granting conditional authorization to ReHeart for severe heart failure and Amusepri for Parkinson's disease. Both treatments use induced pluripotent stem cells that can transform into any cell type, offering new hope for patients with limited treatment options.
SMRTR provides this summary for quick context. The original article belongs to Wired.
Read the original article